z-logo
Premium
Iron overload in patients with myelodysplastic syndromes: An updated overview
Author(s) -
Moukalled Nour M.,
El Rassi Fuad A.,
Temraz Sally N.,
Taher Ali T.
Publication year - 2018
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.31550
Subject(s) - medicine , myelodysplastic syndromes , ineffective erythropoiesis , exacerbation , hepcidin , hematopoietic stem cell transplantation , hemosiderosis , myeloid leukemia , stem cell , haematopoiesis , myeloid , erythropoiesis , transplantation , immunology , anemia , oncology , bone marrow , genetics , biology
Myelodysplastic syndromes (MDS) encompass a heterogeneous group of clonal hematopoietic stem cell disorders characterized by a broad clinical spectrum related to ineffective hematopoiesis leading to unilineage or multilineage cytopenias, with a high propensity for transformation to acute myeloid leukemia. Iron overload has been recently identified as one of the important conditions complicating the management of these diverse disorders. The accumulation of iron is mainly related to chronic transfusions; however, evidence suggests a possible role for ineffective erythropoiesis and increased intestinal absorption of iron, related to altered hepcidin and growth differentiation factor‐15 levels in the development of hemosiderosis in patients with MDS. In addition to its suggested role in the exacerbation of ineffective erythropoiesis, multiple reports have identified a prognostic implication for the development of iron overload in patients with MDS, with an improvement in overall survival after the initiation of iron chelation therapy. This review includes a detailed discussion of iron overload in patients with MDS whether they are undergoing supportive therapy or curative hematopoietic stem cell transplantation, with a focus on the mechanism, diagnosis, and effect on survival as well as the optimal management of this highly variable complication.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here